Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Apparatus New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Nov 01, 2024
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Nov 17, 2024
Read More Medical Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer! Nov 11, 2024
